⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for haploidentical transplantation

Every month we try and update this database with for haploidentical transplantation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT ChildrenNCT02646839
Acute Lymphobla...
Acute Myeloid L...
Myelodysplastic...
CliniMacs TCR a...
- 21 YearsChildren's Hospital Los Angeles
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical TransplantationNCT03159702
Hematological M...
Multiple Myelom...
Evomela
Fludarabine
Total Body Irra...
18 Years - Medical College of Wisconsin
TCDαβ/CD45RA Haploidentical Transplantation in Children With LeukemiaNCT04033627
Relapsed Pediat...
Acute Graft-Ver...
Relapsed Pediat...
In Vitro T cell...
2 Months - 18 YearsShanghai Children's Medical Center
Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCTNCT05290545
Hematological M...
Hematopoietic S...
PBSCs
Cord
BMSCs
18 Years - 65 YearsNanfang Hospital, Southern Medical University
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT ChildrenNCT02646839
Acute Lymphobla...
Acute Myeloid L...
Myelodysplastic...
CliniMacs TCR a...
- 21 YearsChildren's Hospital Los Angeles
Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).NCT04687982
Bone Marrow Tra...
Bone Marrow Tra...
Graft Vs Host D...
Infection
Hematological M...
modified donor ...
18 Years - Istituto Clinico Humanitas
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: